Beyond double-stranded RNA-type I IFN induction by 3pRNA and other viral nucleic acids
- PMID: 17969450
- PMCID: PMC7120510
- DOI: 10.1007/978-3-540-71329-6_11
Beyond double-stranded RNA-type I IFN induction by 3pRNA and other viral nucleic acids
Abstract
Production of type I IFN is the key response to viral infection. Since the discovery of type I IFNs in 1957, long double-stranded RNA formed during replication of many viruses was thought to be responsible for type I IFN induction, and for decades double-stranded RNA-activated protein kinase (PKR) was thought to be the receptor. Recently, this picture has dramatically changed. It now became evident that not PKR but two members of the Toll-like receptor (TLR) family, TLR7 and TLR9, and two cytosolic helicases, RIG-I and MDA-5, are responsible for the majority of type I IFNs induced upon recognition of viral nucleic acids. In this review, we focus on the molecular mechanisms by which those innate immune receptors detect viral infection. Based on the recent progress in the field, we now know that TLR7, TLR9, and RIG-I do not require long double-stranded RNA for type I IFN induction.
Similar articles
-
[Recognition of viral nucleic acids and regulation of type I IFN expression].Nihon Rinsho. 2006 Jul;64(7):1236-43. Nihon Rinsho. 2006. PMID: 16838638 Review. Japanese.
-
TRAF6 establishes innate immune responses by activating NF-kappaB and IRF7 upon sensing cytosolic viral RNA and DNA.PLoS One. 2009 May 25;4(5):e5674. doi: 10.1371/journal.pone.0005674. PLoS One. 2009. PMID: 19479062 Free PMC article.
-
Recognition of viral nucleic acids in innate immunity.Rev Med Virol. 2010 Jan;20(1):4-22. doi: 10.1002/rmv.633. Rev Med Virol. 2010. PMID: 20041442 Review.
-
[Cell type specific involvement of RIG-I in antiviral responses].Nihon Rinsho. 2006 Jul;64(7):1244-7. Nihon Rinsho. 2006. PMID: 16838639 Review. Japanese.
-
[Nucleic acids recognition by innate immunity].Uirusu. 2012 Jun;62(1):39-45. doi: 10.2222/jsv.62.39. Uirusu. 2012. PMID: 23189823 Review. Japanese.
Cited by
-
The chase for the RIG-I ligand--recent advances.Mol Ther. 2010 Jul;18(7):1254-62. doi: 10.1038/mt.2010.90. Epub 2010 May 11. Mol Ther. 2010. PMID: 20461060 Free PMC article. Review.
-
Gene silencing below the immune radar.J Clin Invest. 2009 Mar;119(3):438-42. doi: 10.1172/jci38475. J Clin Invest. 2009. PMID: 19306498 Free PMC article.
-
Immune- and miRNA-response to recombinant interferon beta-1a: a biomarker evaluation study to guide the development of novel type I interferon- based therapies.BMC Pharmacol Toxicol. 2015 Sep 22;16:25. doi: 10.1186/s40360-015-0025-x. BMC Pharmacol Toxicol. 2015. PMID: 26392348 Free PMC article. Clinical Trial.
-
Chemically Modified Oligonucleotides Modulate an Epigenetically Varied and Transient Form of Transcription Silencing of HIV-1 in Human Cells.Mol Ther Nucleic Acids. 2012 Apr 10;1(4):e16. doi: 10.1038/mtna.2012.8. Mol Ther Nucleic Acids. 2012. PMID: 23343927 Free PMC article.
-
Processing of genome 5' termini as a strategy of negative-strand RNA viruses to avoid RIG-I-dependent interferon induction.PLoS One. 2008 Apr 30;3(4):e2032. doi: 10.1371/journal.pone.0002032. PLoS One. 2008. PMID: 18446221 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical